DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

AMAG Pharmaceuticals Q4 EPS $(5.89) Does Not Compare To $(0.36) Estimate, Sales $89.7M Beat $88.39M Estimate

AMAG Pharmaceuticals (NASDAQ:AMAG) reported quarterly losses of $(5.89) per share which missed the analyst consensus estimate of $(0.36) by 1536.11 percent. This is a 881.67 percent decrease over losses of $(0.6) per

Benzinga · 03/04/2020 12:13

AMAG Pharmaceuticals (NASDAQ:AMAG) reported quarterly losses of $(5.89) per share which missed the analyst consensus estimate of $(0.36) by 1536.11 percent. This is a 881.67 percent decrease over losses of $(0.6) per share from the same period last year. The company reported quarterly sales of $89.7 million which beat the analyst consensus estimate of $88.39 million by 1.48 percent. This is a 1.79 percent increase over sales of $88.122 million the same period last year.